微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 51.31% | 23.69% | 15.9% | 66/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 44.27% | -6.31% | 12.73% | 93/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 39.27% | -21.23% | -3.93% | 103/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 40.87% | -22.39% | -1.46% | 96/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 41.48% | -23.28% | -12.21% | 92/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 47.25% | 15.43% | -5.22% | 85/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 49.86% | 2% | -5.34% | 79/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 52.67% | 29.42% | -2.59% | 73/159 | 38.65% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 54.07% | 2% | 32.08% | 70/159 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 40.94% | -2.77% | 0.59% | 102/159 | 53.74% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 40.7% | -8.17% | -3.34% | 97/159 | 21.74% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 42.1% | -15.89% | -5% | 96/159 | 55.21% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 44.32% | -2.23% | -11.47% | 86/159 | 47.45% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 50.06% | 10.02% | 10.02% | 81/159 | -144.37% | 首药控股 | 99.93% | 行业排名> |
| 2019-12-31 | 45.5% | 23.4% | 0.38% | 89/159 | -1213.38% | 艾力斯 | 99.41% | 行业排名> |
| 2019-06-30 | 45.33% | 43.09% | 22.93% | 71/159 | 55.47% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 36.87% | 2% | 16.39% | 102/159 | -205.91% | 艾力斯 | 99.4% | 行业排名> |
| 2018-06-30 | 31.68% | 2% | 2% | 89/159 | 53.68% | 首药控股 | 99.94% | 行业排名> |